Trial site
The Miriam Hospital
Providence, Rhode Island 02906, United StatesNot linked to an institution yet
- 13running trials
- 19closed trials
The trials here
What the 33 trials at this site are about, from their registry records.
- Phase
- Phase 26 trials
- Phase 32 trials
- Phase 1/21 trial
- Status
- Completed17 trials
- Active, not recruiting8 trials
- Recruiting4 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- The Miriam Hospital9 trials
- Brown University3 trials
- Pfizer3 trials
- Medtronic Vascular2 trials
- Shockwave Medical, Inc.2 trials
- and 14 more
Running trials
Recruiting
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)
NCT06636786· Phase 2· University of North Carolina, Chapel Hill· Source
Contact: Carolyn Ortega
Recruiting
Weight Management Intervention in College: A Pilot
NCT06994923· The Miriam Hospital· Source
Contact: Jacqueline F Hayes, PhD
Recruiting
The THOR IDE Study
NCT05916950· Philips Clinical & Medical Affairs Global· Source
Contact: Lina Felix
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
NCT06152575· Phase 3· Pfizer· Source
Active, not recruiting
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
NCT06111235· Phase 3· CG Oncology, Inc.· Source
Active, not recruiting
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
NCT05907564· Inquis Medical, Inc.· Source
Active, not recruiting
Mind Your Heart-II
NCT05431192· The Miriam Hospital· Source
Recruiting
CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
NCT05145478· Yale University· Source
Contact: Peter A Soukas, MD
Active, not recruiting
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
NCT05198674· Medtronic Vascular· Source
Active, not recruiting
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
NCT03485209· Phase 2· Seagen, a wholly owned subsidiary of Pfizer· Source
Active, not recruiting
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
NCT03355976· Phase 2· Brown University· Source
Active, not recruiting
Predictors of De-novo Development of Obstructive Sleep Apnea in Pregnancy
NCT02917876· The Miriam Hospital· Source
Active, not recruiting
Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)
NCT02412696· The Miriam Hospital· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
Healthy Heart Habits-2
NCT06440278· The Miriam Hospital· Source
Terminated
Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
NCT05626322· Phase 1/2· Pfizer· Source
Completed
FORWARD PAD IDE Study With the Shockwave Javelin IVL Catheter
NCT05858905· Shockwave Medical, Inc.· Source
Completed
Weight Management Intervention in College: A Pilot Study
NCT05895461· The Miriam Hospital· Source
Terminated
Tack Optimized Balloon Angioplasty Post-Market Study
NCT05361967· Spectranetics Corporation· Source
Completed
A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)
NCT05358353· ReFlow Medical, Inc.· Source
Completed
Values-Affirmation + Education Intervention Targeting Medication Adherence in Older Adults With Heart Failure
NCT05575375· The Miriam Hospital· Source
Completed
A Peer-Driven Intervention to Increase PrEP Uptake Among Minority MSM
NCT05161663· The Miriam Hospital· Source
Completed
Open Trial to Improve Retention in Care for Persons With HIV Who Use Substances
NCT05101044· Brown University· Source
Completed
Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System
NCT05007925· Shockwave Medical, Inc.· Source
Completed
Teen Weight Control
NCT04861636· The Miriam Hospital· Source
Completed
Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population
NCT04801420· Phase 2· Pfizer· Source
Completed
Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System
NCT04580160· Vesper Medical, Inc.· Source
Completed
Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung
NCT03589547· Phase 2· Brown University· Source
Completed
The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study
NCT04130737· Endologix· Source
Completed
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
NCT03241459· SurModics, Inc.· Source
Completed
Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma
NCT02412228· Phase 2· John L. Reagan· Source
Completed
SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System
NCT02439775· Medtronic Vascular· Source
Completed
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
NCT02089217· Mayo Clinic· Source
Report an error